Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,375 | -100,980 | -41,824 | -217,863 | -166,748 |
| Depreciation Amortization | 20,810 | 12,320 | 5,292 | 16,514 | 11,562 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -11,177 |
| Accounts receivable | -2,508 | -8,050 | -4,098 | -9,622 | -10,284 |
| Accounts payable and accrued liabilities | -4,431 | -4,211 | 3,282 | 7,383 | 466 |
| Other Working Capital | -1,450 | -13,465 | -11,619 | -5,356 | -7,881 |
| Other Operating Activity | 24,184 | 16,028 | -5,103 | 84,559 | 60,944 |
| Operating Cash Flow | $-121,770 | $-98,358 | $-54,070 | $-124,385 | $-123,118 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25,386 | -20,877 | -11,824 | -101,857 | -85,395 |
| Net Acquisitions | N/A | N/A | N/A | -13,915 | -8,160 |
| Purchase Of Investment | -58,255 | -50,434 | -22,647 | -217,639 | -217,639 |
| Sale Of Investment | 136,500 | 105,500 | 27,500 | 100,481 | 75,481 |
| Investing Cash Flow | $52,859 | $34,189 | $-6,971 | $-232,930 | $-235,713 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1,558 | -1,558 |
| Common Stock Issued | 3,744 | 3,391 | 604 | 279,846 | 276,982 |
| Common Stock Repurchased | -3,275 | -2,261 | -999 | -7,754 | -6,130 |
| Financing Cash Flow | $469 | $1,130 | $-395 | $270,534 | $269,294 |
| Exchange Rate Effect | 21 | 341 | 268 | -319 | -1 |
| Beginning Cash Position | 380,259 | 380,259 | 380,259 | 467,359 | 467,359 |
| End Cash Position | 311,838 | 317,561 | 319,091 | 380,259 | 377,821 |
| Net Cash Flow | $-68,421 | $-62,698 | $-61,168 | $-87,100 | $-89,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,770 | -98,358 | -54,070 | -124,385 | -123,118 |
| Capital Expenditure | -25,386 | -20,877 | -11,824 | -101,857 | -85,395 |
| Free Cash Flow | -147,156 | -119,235 | -65,894 | -226,242 | -208,513 |